Company research
OSR Health, Inc.
CIK 1840425Updated Sep 24, 2026
Name history
OSR Holdings, Inc. · through Jun 11, 2026Bellevue Life Sciences Acquisition Corp. · through Feb 13, 2025
OSRH price & chart
Loading TradingView…
NASDAQ:OSRH on TradingView ↗About the company
OSR Health, Inc. (NASDAQ:OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSR Health engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.osr-health.com
In the news
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care News provided by OSR Holdings Oct 14, 2025, 08:30 ET Share this article Share to X Share this article Share to X BELLEVUE, Wash. , Oct. 14, 2025 /PRNewsw ↗
Recent filings
Other Events
Items 8.01
Other Events
Items 8.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD Disclosure
Items 3.01, 7.01, 9.01
SCHEDULE 13G/A filing
10-Q filing
Show 5 more recent filings
Submission of Matters to a Vote of Security Holders
Items 5.07
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
DEF 14A filing
PRE 14A filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 171,238,248Source | 2,303,041Source | 36,627,733Source | 1,225,854Source |
| Property, Plant and Equipment, NetUSD | 169,130Source | 2,334Source | — | — |
| GoodwillUSD | 24,949,806Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 142,462,634Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,700,273Source | 66,135Source | 15,419Source | 124,501Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 319,304Source | — | — | — |
| Inventory, NetUSD | 196,432Source | — | — | — |
| Assets, CurrentUSD | 2,816,821Source | 455,398Source | 22,627Source | 124,501Source |
| Operating Lease, Right-of-Use AssetUSD | 60,425Source | — | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 44,200,845Source | 8,788,809Source | 4,108,272Source | 1,263,362Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | 0Source | — |
| Common Stock, Value, IssuedUSD | 2,660Source | 216Source | 216Source | 173Source |
| Additional Paid in CapitalUSD | — | — | — | 24,827Source |
| Retained Earnings (Accumulated Deficit)USD | -37,169,881Source | -8,333,627Source | -3,907,008Source | -62,508Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 3,835,861Source | — | — | — |
| Stockholders' Equity Attributable to ParentUSD | — | -8,333,411Source | -3,906,792Source | -37,508Source |
| Additional Paid in Capital, Common StockUSD | 110,966,975Source | — | — | — |
| Liabilities and EquityUSD | 171,238,248Source | 2,303,041Source | 36,627,733Source | 1,225,854Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 17,165,292Source | 6,718,809Source | 2,038,272Source | 1,263,362Source |
| Operating Lease, Liability, CurrentUSD | 46,961Source | — | — | — |
| Operating Lease, Liability, NoncurrentUSD | 12,551Source | — | — | — |
| Deferred Income Tax Liabilities, NetUSD | 27,021,305Source | — | — | — |
| Other Liabilities, NoncurrentUSD | 1,697Source | — | — | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 49,401,788Source | — | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 957,879Source | — | — | — |
| Deferred Tax Liabilities, NetUSD | 26,820,790Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -27,058,541Source | — | 403,780Source | -35,388Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | -763,734Source | — | — | — |
| Deferred Income Tax Expense (Benefit)USD | — | 739,910Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -4,328,034Source | -2,187,946Source | -818,766Source | -4,235Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | -1,224,794Source | — | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,642,991Source | 35,907,691Source | -33,829,815Source | — |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | 36,232,029Source | 35,995,728Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 8,368,171Source | -33,669,029Source | 34,539,499Source | 123,979Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,700,273Source | 66,135Source | 15,419Source | 124,501Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 506,801Source | — | — | — |
| Income Taxes Paid, NetUSD | 153,618Source | -461,957Source | 16,249Source | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -38,415Source | — | — | — |
| Additional Financial Items | ||||
| AmortizationUSD | 9,298,838Source | — | — | — |
| Amortization of Intangible AssetsUSD | 9,298,838Source | — | — | — |
| DepreciationUSD | 7,269Source | — | — | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | 4,216,055Source | — | — | — |
| General and Administrative ExpenseUSD | — | 3,524,549Source | — | — |
| GoodwillUSD | 24,949,806Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -1,830,700Source | — |
| Income Tax Expense (Benefit)USD | -1,829,820Source | 295,728Source | 540,811Source | — |
| InterestExpenseNonoperatingUSD | 506,196Source | 43,011Source | — | — |
| Inventory Write-downUSD | -8,832Source | — | — | — |
| Investment Income, InterestUSD | 63,883Source | 1,450,228Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | -2,410,879Source | 403,780Source | -35,388Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -9,047,642Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -18,010,899Source | — | — | — |
| Noncash Merger Related CostsUSD | 8,645,747Source | — | — | — |
| Nonoperating Income (Expense)USD | — | 1,409,398Source | — | — |
| Operating Lease, ExpenseUSD | 54,844Source | — | — | — |
| Payments to Acquire InvestmentsUSD | — | 480,000Source | — | — |
| Proceeds from Contributions from AffiliatesUSD | — | 15,000Source | — | 17,000Source |
| Proceeds from Issuance of Common StockUSD | 4,796,471Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 2,905,805Source | — | — | — |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 18,928,908Source | — | 1,830,700Source | 35,388Source |
| Operating Income (Loss)USD | -18,336,003Source | -3,524,549Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -28,888,361Source | -2,115,151Source | — | — |
| Income Tax Expense (Benefit)USD | -1,829,820Source | 295,728Source | 540,811Source | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -9,047,642Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | -2,410,879Source | 403,780Source | -35,388Source |
| Earnings Per Share, BasicUSD per share | -0.92Source | -0.54Source | 0.05Source | -0.01Source |
| Earnings Per Share, DilutedUSD per share | -0.8Source | -0.54Source | 0.05Source | -0.01Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 19,515,034Source | 4,481,692Source | 7,688,260Source | 1,500,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 22,560,443Source | 4,481,692Source | 7,719,699Source | 1,500,000Source |
| Interest Expense (non-operating)USD | 506,196Source | 43,011Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 9,298,838Source | — | — | — |
| Cost of Property Repairs and MaintenanceUSD | 33,393Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | -1,829,820Source | 295,728Source | — | — |
| Direct Costs of Leased and Rented Property or EquipmentUSD | 97,527Source | — | — | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | 4,216,055Source | — | — | — |
| General and Administrative ExpenseUSD | — | 3,524,549Source | — | — |
| Gross ProfitUSD | 592,905Source | — | — | — |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | 944,591Source | -35,388Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -1,830,700Source | -35,388Source |
| Interest Income, OtherUSD | — | 2,181Source | — | — |
| Investment Income, InterestUSD | 63,883Source | 1,450,228Source | — | — |
| Management Fee ExpenseUSD | 17,312Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -18,010,899Source | — | — | — |
| Nonoperating Income (Expense)USD | — | 1,409,398Source | — | — |
| Operating Insurance and Claims Costs, ProductionUSD | 16,962Source | — | — | — |
| Operating Lease, ExpenseUSD | 54,844Source | — | — | — |
| Other General and Administrative ExpenseUSD | 18,928,908Source | — | — | — |
| Other IncomeUSD | — | — | 2,775,291Source | — |
| Research and Development ExpenseUSD | 318,446Source | — | — | — |
Filing attachments
ea030278201ex99-1.htm · 8-K · 2026-08-19
EX-99.1 2 ea030278201ex99-1.htm PRESS RELEASE ISSUED BY OSR HEALTH, INC., DATED AUGUST 19, 2026, TITLED "OSR HEALTH RECEIVES NASDAQ STAFF DELISTING DETERMINATION; INTENDS TO REQUEST HEARINGS PANEL APPEAL." Exhibit 99.1 OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal BELLEVUE, WA / ACCESS Newswire / August 19, 2026 / OSR Health, Inc. (Nasdaq: OSRH) (“OSR Health” or the “Company”) today announced that it has received a written Staff Delis…
Read attachment ↗ea030111401ex99-1.htm · 8-K · 2026-08-07
EX-99.1 2 ea030111401ex99-1.htm PRESS RELEASE, DATED AUGUST 7, 2026, TITLED "OSR HEALTH ISSUES CLARIFICATION REGARDING PRIOR NASDAQ COMMUNICATION AND SHAREHOLDER LOYALTY CVR PROGRAM" Exhibit 99.1 OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program BELLEVUE, WA / ACCESS Newswire / August 7, 2026 / OSR Health, Inc. (NASDAQ: OSRH) (“OSR Health” or the “Company”) today issued a clarification regarding its press release dated July 31, 2026 co…
Read attachment ↗ea030011101ex99-1.htm · 8-K · 2026-07-31
EX-99.1 2 ea030011101ex99-1.htm PRESS RELEASE, DATED JULY 31, 2026, TITLED "OSR HEALTH SECURES NASDAQ COMMUNICATION: LOYALTY CVR PROGRAM WILL NOT TRIGGER A PRICE ADJUSTMENT" Exhibit 99.1 OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment Bellevue, WA - July 31, 2026 - OSR Health, Inc. (NASDAQ: OSRH) (“OSR Health” or the “Company”) today announced that The Nasdaq Stock Market (“Nasdaq”) stated in a verbal communication with the Company that the …
Read attachment ↗ea028950301ex99-2.htm · 8-K/A · 2026-05-06
EX-99.2 2 ea028950301ex99-2.htm FAIRNESS OPINION OF AVANCE LIFE SCIENCES AG, DATED APRIL 21, 2026 Exhibit 99.2 Avance, Basel GmbH - Confidential FAIRNESS OPINION regarding the Proposed Global License Agreement for VXM01 among OSR Holdings, Inc. and Vaximm AG (collectively, the “Licensor”) and BCM Europe AG (the “Licensee”) AVANCE, BASEL GMBH Basel, Switzerland April 21, 2026 C O N F I D E N T I A L TABLE OF CONTENTS I. Introduction …
Read attachment ↗ea028846501ex99-1.htm · 8-K · 2026-04-30
EX-99.1 4 ea028846501ex99-1.htm PRESS RELEASE, DATED APRIL 29, 2026, TITLED "OSR HOLDINGS EXECUTES DEFINITIVE $815 MILLION GLOBAL LICENSE AGREEMENT FOR VXM01 WITH BCM EUROPE" Exhibit 99.1 OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe Largest shareholder pledges entire equity stake as collateral for milestone obligations, reinforcing alignment with public shareholders Bellevue, WA - April 29, 2026 - OSR Holdings, Inc. (NASDAQ: OSRH) today …
Read attachment ↗ea028555001ex99-1.htm · 8-K · 2026-04-09
EX-99.1 5 ea028555001ex99-1.htm PRESS RELEASE, DATED APRIL 9, 2026, TITLED "OSR HOLDINGS ELIMINATES $2.02 MILLION WARRANT OVERHANG WITH PREMIUM-PRICED CONVERTIBLE NOTE" Exhibit 99.1 OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note Bellevue, WA - April 9, 2026 - OSR Holdings, Inc. (NASDAQ: OSRH) (“OSR Holdings” or the “Company”) today announced a strategic transaction for capital structure optimization with White Lion GBM Innovation Fund (“White Li…
Read attachment ↗